133 related articles for article (PubMed ID: 17387702)
21. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
22. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.
Costea I; Moghrabi A; Laverdiere C; Graziani A; Krajinovic M
Haematologica; 2006 Aug; 91(8):1113-6. PubMed ID: 16870553
[TBL] [Abstract][Full Text] [Related]
23. Severe methotrexate toxicity precipitated by intravenous radiographic contrast.
Harned TM; Mascarenhas L
J Pediatr Hematol Oncol; 2007 Jul; 29(7):496-9. PubMed ID: 17609630
[TBL] [Abstract][Full Text] [Related]
24. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
25. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Azarpira N; Ramzi M; Aghdaie MH; Daraie M; Geramizadeh B
Exp Clin Transplant; 2007 Dec; 5(2):693-7. PubMed ID: 18194124
[TBL] [Abstract][Full Text] [Related]
26. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
[TBL] [Abstract][Full Text] [Related]
27. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate.
Chiusolo P; Reddiconto G; Casorelli I; Laurenti L; Sorà F; Mele L; Annino L; Leone G; Sica S
Ann Oncol; 2002 Dec; 13(12):1915-8. PubMed ID: 12453860
[TBL] [Abstract][Full Text] [Related]
28. [Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia].
Tatsumoto C; Kawakami K; Nagayama J; Kawano H
Rinsho Ketsueki; 2004 Oct; 45(10):1100-4. PubMed ID: 15553044
[TBL] [Abstract][Full Text] [Related]
29. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
Giovannetti E; Ugrasena DG; Supriyadi E; Vroling L; Azzarello A; de Lange D; Peters GJ; Veerman AJ; Cloos J
Leuk Res; 2008 Jan; 32(1):19-24. PubMed ID: 17395259
[TBL] [Abstract][Full Text] [Related]
30. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
Castro M
J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
[No Abstract] [Full Text] [Related]
31. Polymorphism of the methylenetetrahydrofolate reductase C677T gene with chronic allograft nephropathy in renal transplant recipients.
Azarpira N; Raisjalali G; Darai M
Exp Clin Transplant; 2008 Mar; 6(1):54-8. PubMed ID: 18405246
[TBL] [Abstract][Full Text] [Related]
32. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
33. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
34. Acute transient cerebral toxicity associated with administration of high-dose methotrexate.
Mittal R; Mottl H; Nemec J
Med Princ Pract; 2005; 14(3):202-4. PubMed ID: 15863997
[TBL] [Abstract][Full Text] [Related]
35. Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation.
Kalayoglu-Besisik S; Caliskan Y; Sargin D; Gurses N; Ozbek U
Transplantation; 2003 Dec; 76(12):1775-7. PubMed ID: 14688536
[No Abstract] [Full Text] [Related]
36. [Delayed clearance of methotrexate in a patient with malignant lymphoma who developed renal failure].
Wakita A; Komatsu H; Banno S; Nitta M; Nagai H; Uchida T; Murase T; Nakahara Y; Tanaka M
Gan To Kagaku Ryoho; 1995 Feb; 22(2):285-8. PubMed ID: 7857106
[TBL] [Abstract][Full Text] [Related]
37. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis.
Ahmad S; Shen FH; Bleyer WA
Arch Intern Med; 1978 Jul; 138(7):1146-7. PubMed ID: 666479
[TBL] [Abstract][Full Text] [Related]
39. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
40. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]